Navigation Links
AHIP Statement on Daschle Nomination
Date:12/11/2008

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement in response to the nomination of Senator Tom Daschle to be the next Secretary of the U.S. Department of Health and Human Services:

"The American people will welcome the nomination of Senator Tom Daschle because it signals that the incoming administration intends to prioritize comprehensive health care reform. Senator Daschle is exceptionally well qualified to bring people together in support of universal coverage, cost-containment, and improved quality."

AHIP's Board of Directors last week issued a comprehensive health care reform proposal to cover all Americans, reduce the growth of health care costs, and improve the quality and value of care. To learn more about AHIP's proposal, please visit www.americanhealthsolution.org.

America's Health Insurance Plans - Providing Health Benefits to More Than 200 Million Americans


'/>"/>
SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New statement outlines essentials of heart failure clinics
2. United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program
3. Statement on Nomination of Retired Gen. Eric Shinseki by VA Secretary Dr. James B. Peake
4. American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center
5. Firearms Industry Statement on MN Dept of Agriculture Game Donation Testing
6. American Academy of Dermatology Issues Position Statement on Vitamin D
7. Statement of DNC Chairman Howard Dean on World AIDS Day
8. TFAH Statement: FDA Food Protection Plan is Insufficient
9. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
10. International Formula Council Statement on Melamine and Infant Formulas
11. GPhA Statement on FTC Roundtable on Biogenerics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... FL (PRWEB) , ... February 10, 2016 , ... AxoGen, ... market, will report results for the fourth quarter and full year ended December 31, ... host a conference call and webcast for the investment community following the release at ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp ... book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... The book’s publication date is March 16, 2016. A free review copy is ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... Country Club) announced that it has been awarded the prestigious Distinguished Emerald Club ... World award program conducted by BoardRoom magazine, one of the most respected trade ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength ... solution that ensures the integrity of biological samples while operating at ultra-high pressures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced ... described as a "clinical trial triumph" after one of ... complete cancer remission. Daniel Vallera , ... Cancer Center. --> Daniel Vallera , ... Cancer Center. --> An article on ...
Breaking Medicine Technology: